[VIEW] agent=Director, Marketing Insights | scenario_id=73 | rounds=20

--- Round 0 ---
[R0.1] VP, Theatrical Distribution (speak, public): Given the competitive release pressure with our major competitor opening on July 25, 2026, we need to consider our options carefully. Moving our release date three weeks later could lead to an 8% reduction in our opening weekend according to our internal model. We should also validate the availability of our premium format allocation, especially since our IMAX hold expires on March 28, 2026. Let's discuss the implications of these factors on our decision-making process.
[R0.2] Director, Marketing Insights (speak, private to=Business Affairs Counsel): I can share that our trailer engagement has been quite strong, with 18 million views in the first week and a 41% completion rate. This indicates a solid level of interest that we could leverage in our marketing strategy. Additionally, our domestic awareness tracking shows an unaided awareness rate of 32% among our target demographic of 13-34 year-olds, which is promising. However, I'd like to understand more about the potential legal constraints and any obligations we might have regarding the release date and premium format allocation. Can you provide insights on that?
[R0.3] Business Affairs Counsel (speak, private to=Director, Marketing Insights): I appreciate the insights on trailer engagement and awareness. Regarding the potential legal constraints, we need to consider that any date shift must respect the director's consultation rights, which require a notice period of 10 business days. Additionally, the exclusivity for premium large format (PLF) films lasts for 21 days, and we have a screen count floor of 350. Therefore, we need to ensure these timelines align with our proposed changes. Would you like more details on any specific aspect?

--- Round 1 ---
[R1.1] VP, Theatrical Distribution (speak, public): We need to ensure we have a strong marketing strategy in place, especially considering the competitive landscape. How can we leverage our existing audience insights to optimize our release strategy? Additionally, can we confirm the availability of our premium formats by the IMAX hold expiration date?
[R1.2] Director, Marketing Insights (speak, public): Given our strong trailer engagement with 18 million views and a 41% completion rate, we should leverage these insights to craft a compelling marketing strategy that aligns with our release date considerations. Additionally, regarding the premium formats, we need to ensure that we have confirmed availability before the IMAX hold expiration on March 28, 2026. Can we discuss how we can optimize our marketing efforts based on these metrics and ensure compliance with the legal constraints outlined?
[R1.3] Business Affairs Counsel (speak, public): To summarize, we need to ensure that any release date move complies with the director's consultation rights, which require a 10-day notice. Furthermore, we must account for the 21-day exclusivity period for premium large format films and ensure we maintain a minimum screen count of 350. Given the IMAX hold expiration date of March 28, 2026, I recommend confirming the availability of our premium formats as soon as possible. Let's ensure our marketing strategy aligns with these timelines and constraints.

--- Round 2 ---
[R2.1] VP, Theatrical Distribution (speak, private to=Director, Marketing Insights,Business Affairs Counsel): I appreciate the insights on marketing effectiveness. Given the strong engagement metrics we've seen, how can we prioritize our marketing efforts to maximize audience reach in light of the competitive release pressure? Also, can we confirm the premium format availability ahead of the IMAX hold expiration?
[R2.2] Director, Marketing Insights (speak, private to=VP, Theatrical Distribution,Business Affairs Counsel): To optimize our marketing strategy given the competitive landscape, we should focus on targeted outreach to the demographic showing the highest engagement, especially leveraging our strong trailer views. Additionally, can we confirm premium format availability as soon as possible to align with our timing strategy?
[R2.3] Business Affairs Counsel (leave, public): 

--- Round 3 ---
[R3.1] VP, Theatrical Distribution (leave, public): 
[R3.2] Director, Marketing Insights (leave, public): 
[R3.3] Business Affairs Counsel (leave, public): 

--- Round 4 ---
[R4.1] VP, Theatrical Distribution (leave, public): 
[R4.2] Director, Marketing Insights (leave, public): 
[R4.3] Business Affairs Counsel (leave, public): 

--- Round 5 ---
[R5.1] VP, Theatrical Distribution (leave, public): 
[R5.2] Director, Marketing Insights (leave, public): 
[R5.3] Business Affairs Counsel (leave, public): 

--- Round 6 ---
[R6.1] VP, Theatrical Distribution (leave, public): 
[R6.2] Director, Marketing Insights (leave, public): 
[R6.3] Business Affairs Counsel (leave, public): 

--- Round 7 ---
[R7.1] VP, Theatrical Distribution (leave, public): 
[R7.2] Director, Marketing Insights (leave, public): 
[R7.3] Business Affairs Counsel (leave, public): 

--- Round 8 ---
[R8.1] VP, Theatrical Distribution (leave, public): 
[R8.2] Director, Marketing Insights (leave, public): 
[R8.3] Business Affairs Counsel (leave, public): 

--- Round 9 ---
[R9.1] VP, Theatrical Distribution (leave, public): 
[R9.2] Director, Marketing Insights (leave, public): 
[R9.3] Business Affairs Counsel (leave, public): 

--- Round 10 ---
[R10.1] VP, Theatrical Distribution (leave, public): 
[R10.2] Director, Marketing Insights (leave, public): 
[R10.3] Business Affairs Counsel (leave, public): 

--- Round 11 ---
[R11.1] VP, Theatrical Distribution (leave, public): 
[R11.2] Director, Marketing Insights (leave, public): 
[R11.3] Business Affairs Counsel (leave, public): 

--- Round 12 ---
[R12.1] VP, Theatrical Distribution (leave, public): 
[R12.2] Director, Marketing Insights (leave, public): 
[R12.3] Business Affairs Counsel (leave, public): 

--- Round 13 ---
[R13.1] VP, Theatrical Distribution (leave, public): 
[R13.2] Director, Marketing Insights (leave, public): 
[R13.3] Business Affairs Counsel (leave, public): 

--- Round 14 ---
[R14.1] VP, Theatrical Distribution (leave, public): 
[R14.2] Director, Marketing Insights (leave, public): 
[R14.3] Business Affairs Counsel (leave, public): 

--- Round 15 ---
[R15.1] VP, Theatrical Distribution (leave, public): 
[R15.2] Director, Marketing Insights (leave, public): 
[R15.3] Business Affairs Counsel (leave, public): 

--- Round 16 ---
[R16.1] VP, Theatrical Distribution (leave, public): 
[R16.2] Director, Marketing Insights (leave, public): 
[R16.3] Business Affairs Counsel (leave, public): 

--- Round 17 ---
[R17.1] VP, Theatrical Distribution (leave, public): 
[R17.2] Director, Marketing Insights (leave, public): 
[R17.3] Business Affairs Counsel (leave, public): 

--- Round 18 ---
[R18.1] VP, Theatrical Distribution (leave, public): 
[R18.2] Director, Marketing Insights (leave, public): 
[R18.3] Business Affairs Counsel (leave, public): 

--- Round 19 ---
[R19.1] VP, Theatrical Distribution (leave, public): 
[R19.2] Director, Marketing Insights (leave, public): 
[R19.3] Business Affairs Counsel (leave, public): 

